Litcius/Paper detail

Novel <i>ERG11</i> and <i>TAC1b</i> Mutations Associated with Azole Resistance in Candida auris

Jizhou Li, Alix T. Coste, Maroussia Liechti, Daniel Bachmann, Dominique Sanglard, Frédéric Lamoth

2021Antimicrobial Agents and Chemotherapy77 citationsDOIOpen Access PDF

Abstract

Candida auris is a novel Candida species that has spread in all continents, causing nosocomial outbreaks of invasive candidiasis. C. auris has the ability to develop resistance to all antifungal drug classes. Notably, many C. auris isolates are resistant to the azole drug fluconazole, a standard therapy for invasive candidiasis.

Topics & Concepts

Candida aurisAzoleMicrobiologyBiologyFluconazoleFungi imperfectiDrug resistanceAntifungalAntifungal resistance and susceptibilityFungal Infections and StudiesPneumocystis jirovecii pneumonia detection and treatment
Novel <i>ERG11</i> and <i>TAC1b</i> Mutations Associated with Azole Resistance in Candida auris | Litcius